Literature DB >> 6134650

Minimal increases in glucagon levels enhance glucose production in man with partial hypoinsulinemia.

P E Lins, A Wajngot, U Adamson, M Vranic, S Efendić.   

Abstract

In man a small dose of somatostatin (50 micrograms/h) suppressed moderately basal insulin (5 microU/ml) and glucagon (40 pg/ml) levels. This resulted in a short-lasting hypoglycemia, which was then followed by marginal hyperglycemia throughout the experiment. The addition of a minimal dose of glucagon (0.50 ng/kg/min) to somatostatin normalized basal glucagon levels and resulted in a significant and sustained hyperglycemia. During the first 2 h, hyperglycemia was mainly due to increased glucose production, whereas later on it was maintained by decreased glucose uptake. We conclude that, in man moderately deprived of insulin, even a marginal change in glucagon level induces a long-lasting hyperglycemia.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6134650     DOI: 10.2337/diab.32.7.633

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  14 in total

Review 1.  Exercise and the Regulation of Hepatic Metabolism.

Authors:  Elijah Trefts; Ashley S Williams; David H Wasserman
Journal:  Prog Mol Biol Transl Sci       Date:  2015-08-05       Impact factor: 3.622

Review 2.  Four grams of glucose.

Authors:  David H Wasserman
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-10-07       Impact factor: 4.310

3.  The physiological regulation of glucose flux into muscle in vivo.

Authors:  David H Wasserman; Li Kang; Julio E Ayala; Patrick T Fueger; Robert S Lee-Young
Journal:  J Exp Biol       Date:  2011-01-15       Impact factor: 3.312

4.  Enhancement of glucagon secretion in mouse and human pancreatic alpha cells by protein kinase C (PKC) involves intracellular trafficking of PKCalpha and PKCdelta.

Authors:  Y Z De Marinis; E Zhang; S Amisten; J Taneera; E Renström; P Rorsman; L Eliasson
Journal:  Diabetologia       Date:  2009-12-18       Impact factor: 10.122

Review 5.  Diabetes, insulin and exercise.

Authors:  E A Richter; H Galbo
Journal:  Sports Med       Date:  1986 Jul-Aug       Impact factor: 11.136

6.  Hyperglucagonemia and insulin-mediated glucose metabolism.

Authors:  S Del Prato; P Castellino; D C Simonson; R A DeFronzo
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

7.  Skeletal muscle glycogenolysis is more sensitive to insulin than is glucose transport/phosphorylation. Relation to the insulin-mediated inhibition of hepatic glucose production.

Authors:  L Rossetti; M Hu
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

8.  Pharmacokinetic and pharmacodynamic modeling of a monoclonal antibody antagonist of glucagon receptor in male ob/ob mice.

Authors:  Yvonne Y Lau; Peiming Ma; Leonid Gibiansky; Renee Komorowski; Jin Wang; George Wang; Hai Yan; Murielle M Véniant; Tarundeep Kakkar
Journal:  AAPS J       Date:  2009-10-23       Impact factor: 4.009

9.  Importance of peripheral insulin levels for insulin-induced suppression of glucose production in depancreatized dogs.

Authors:  A Giacca; S J Fisher; Z Q Shi; R Gupta; H L Lickley; M Vranic
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

10.  Intra-islet glucagon secretion and action in the regulation of glucose homeostasis.

Authors:  Qinghua Wang; Xinyun Liang; Susanne Wang
Journal:  Front Physiol       Date:  2013-01-03       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.